← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$724K

Shares

50,000

Price

$14

Filed

Aug 22

Insider

Name

Lowenthal Richard E

Title

PRESIDENT AND CEO

CIK

0001378550

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-08-21

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,196,494

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2025. | The weighted average sale price for the transaction reported was $14.4869 and the range of prices were between $14.31 and $14.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The Reporting Person is trustee of the trust. | The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. | The number of shares reported is comprised of (i) 1,098,499 shares that were previously reported as indirectly held by the Family Trust, (ii) 3,433,512 shares that were previously reported as indirectly held by the Reporting Person's spouse, and (iii) 4,327,189 shares that were previously reported as directly held by the Reporting Person. | The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.

Filing Info

Accession No.

0001415889-25-022761

Form Type

4

Issuer CIK

0001671858

Lowenthal Richard E's History

Date Ticker Type Value
2026-01-02 SPRY A $0
2026-01-02 SPRY A $0
2025-08-21 SPRY $724K

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.